Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Bone Neoplasms. Found 7 abstracts

Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA, Movva S, Davis LE, Okuno SH, Reed DR, Crowley J, Butterfield LH, Salazar R, Rodriguez-Canales J, Lazar AJ, Wistuba, Baker LH, Maki RG, Reinke D, Patel S. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol. 2017 Nov;18(11):1493-501.
Aaron H, Azadarmaki R, Lango MN. Unilateral Vocal Cord Motion Impairment After 1 Dose of Vincristine: Case Report and Literature Review. Am J Ther. 2016 Mar;23(2):e621-3.
Hurwitz MD, Ghanouni P, Kanaev SV, Iozeffi D, Gianfelice D, Fennessy FM, Kuten A, Meyer JE, LeBlang SD, Roberts A, Choi J, Larner JM, Napoli A, Turkevich VG, Inbar Y, Tempany CM, Pfeffer RM. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results. Journal of the National Cancer Institute. 2014 May;106(5).   PMCID: 4112926
Kosteva J, Langer C. The changing landscape of the medical management of skeletal metastases in nonsmall cell lung cancer. Curr Opin Oncol. 2008 Mar;20(2):155-61.
Langer CJ. Role of zoledronic acid in the setting of bone metastases from non-small-cell lung cancer. Clinical lung cancer. 2005 Jan;6(5):314-6, 2005 Mar.
Sundermeyer ML, Meropol NJ, Rogatko A, Wang H, Cohen SJ. Changing patterns of bone and brain metastases in patients with colorectal cancer. Clinical Colorectal Cancer. 2005 Jul;5(2):108-13.
Zhang H, Merchant MS, Chua KS, Khanna C, Helman LJ, Telford B, Ward Y, Summers J, Toretsky J, Thomas EK, June CH, Mackall CL. Tumor expression of 4-1BB ligand sustains tumor lytic T cells. Cancer Biol Ther. 2003 Sep;2(5):579-86.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Bone Neoplasms

Bone Neoplasms Female Male Middle Aged Adult pathology adverse effects therapy Aged metabolism drug therapy pa [Pathology] Lung Neoplasms Brain Neoplasms sc [Secondary] dt [Drug Therapy] secondary Use] ae [Adverse Effects] Non-Small-Cell Lung Carcinoma Mice tu [Therapeutic Use] 0 (Imidazoles) Magnetic Resonance Imaging 118072-93-8 (zoledronic acid) Patient Safety Incidence prevention & control Sarcoma High-Intensity Focused Ultrasound Ablation Young Adult Dendritic Cells 0 (Antineoplastic Combined Chemotherapy Protocols) Non-US Gov't Support chemically induced Drug Administration Schedule et [Etiology] Secondary Hypertrophic Osteoarthropathy 0 (Diphosphonates) Squamous Cell Carcinoma th [Therapy] Imidazoles Drug Dose-Response Relationship Maximum Tolerated Dose Tumor Necrosis Factor Philadelphia Treatment Outcome Lymphocyte Activation mo [Mortality] CD3 Antigens Diphosphonates Survival Analysis CD8 Antigens Neoplasm Metastasis Ewing Sarcoma Monoclonal Antibodies-Humanized Soft Tissue Neoplasms Antigen Receptors-T-Cell Academic Medical Centers methods Single-Blind Method Tumor-Infiltrating Lymphocytes Neoplasms Vocal Cord Paralysis Adenocarcinoma Comparative Study co [Complications] tu [Therapeutic statistics & numerical data Retrospective Studies Human Prognosis Colorectal Neoplasms Ligands Adolescent Disease Progression Antineoplastic Agents Kaplan-Meier Estimate Intravenous Infusions United States T-Lymphocytes immunology Antineoplastic Combined Chemotherapy Protocols SCID Mice Ewing's Sarcoma ultrasonography Phytogenic Antineoplastic Agents Cytotoxic T-Lymphocytes Vincristine Neoplasm Invasiveness Multivariate Analysis 80 and over Aged Biological Tumor Markers Disease-Free Survival CD28 Antigens 0 (Antineoplastic Agents) Neoplasm Staging ep [Epidemiology] NIH Research Support-Extramural Confidence Intervals Survival Rate therapeutic use mortality
Last updated on Friday, January 03, 2020